Our Portfolio
With a specialized portfolio, Multicare helps provide patients with reliable access to therapies for rare and highly complex diseases.
Kanuma® (sebelipase alfa)
Soliris® (eculizumabe)
Strensiq® (alfa-asfotase)
Ultomiris® (Ravulizumabe)
Kuvan® (sapropterin dihydrochloride)
Naglazyme® (galsulfase)
Vimizim® (elosulfase alfa)
Voxzogo™ (vosoritide) Injection
Tepezza® (teprotumumabe)
Orfadin® (nitisinona)
Carbaglu® (ácido carglúmico)
Cystadane® (betaína)
Neoprofen® (Levolisinato de ibuprofeno)
Panhematin® (hemina)
Signifor® LP (pamoato de pasireotida)
Upelior® (diaspartato de pasireotida)
Kalydeco® (ivacaftor)
Orkambi® (lumacaftor/ivacaftor)
Symdeko® (tezacaftor/ivacaftor)
Trikafta® (elexacaftor / tezacaftor / ivacaftor + ivacaftor)
Need help finding the product you’re looking for?
Talk to our team. Our scope of services is designed to provide high-quality end-to-end support for accessing medicines.
Partner Laboratories - All brands, trademarks, and logos are the exclusive property of the producers (laboratories) and are under their copyright.